| dc.relation | 1. Tulla M, Berthold F, Graf N, Rutkowski S, Von Schweinitz D, Spix C, et al. Incidence,
trends, and survival of children with embryonal tumors. Pediatrics. 2015;136(3):e623–32.
2. Allan BJ, Parikh PP, Diaz S, Perez EA, Neville HL, Sola JE. Predictors of survival and
incidence of hepatoblastoma in the paediatric population. Hpb. 2013;15(10):741–6. doi:
10.1111/hpb.12112
3. Chung EM, Lattin GE, Cube R, Lewis RB, Marichal-Hernández C, Shawhan R, et al. From the
Archives of the AFIP: Pediatric Liver Masses: Radiologic-Pathologic Correlation Part 2.
Malignant Tumors. RadioGraphics. 2011 Mar;31(2):483–507.
4. Uribe CJ, Amado AM, Ramírez G, Alarcón IC. Cáncer infantil en el área metropolitana de
Bucaramanga, Colombia, 2003-2007. MedUNAB. 2011 ago-nov;14(2): 86-93. Disponible
en: https://revistas.unab.edu.co/index.php/medunab/article/view/1383.
5. Caicedo LA, Sabogal A, Serrano O, Villegas JI, Botero V, Agudelo MT, et al.
Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant
Center. Transplant direct. 2017;3(6):e165.
6. Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, et al. Risk-stratified
staging in paediatric hepatoblastoma: A unified analysis from the Children’s Hepatic
Tumors International Collaboration. Lancet Oncol. 2017;18(1):122–31.
7. Schnater, J.M. The way forward in hepatoblastoma: A study of epidemiology, gene
expresión patterns, and the development of a tumor model [PhD tesis en Internet].
Amsterdam (Holanda): University of Amsterdam; 2006 [citado 2019 oct 27]. Disponible
en: https://hdl.handle.net/11245/1.258938
8. Huang LC, Ho M, Chang WC, Chen HY, Hung YC, Chiu TH. Prenatal diagnosis of fetal
hepatoblastoma with a good neonatal outcome: Case report and narrative literature
review. Pediatr Hematol Oncol. 2011;28(2):150–4.
9. Spector LG, Birch J. The Epidemiology of Hepatoblastoma. Pediatr Blood Cancer.
2013;60(2, poster 619):S41.
10. Misick OS. A case of teratoma hepatis. J Pathol Bacteriol. 1898;5(1):128–36.
11. Ishak KG, Glunz PR. Hepatoblastoma and hepatocarcinoma in infancy and childhood.
Report of 47 cases. Cancer.1967 marzo;(20)3:396–422. https://doi.org/10.1002/1097-
0142(1967)20:3<396::AID-CNCR2820200308>3.0.CO;2-O
12. Monsalve J, Kapur J, Malkin D, Babyn P. Imaging of cancer predisposition syndromes in
children. Pediatr Radiol. 2018;48(9):1364–75.
13. Mussa A, Russo S, Larizza L, Riccio A, Ferrero GB. (Epi)genotype-phenotype correlations in
Beckwith-Wiedemann syndrome: A paradigm for genomic medicine. Clin Genet.
2016;89(4):403–15.
14. Meyers RL. Tumors of the liver in children. Surg Oncol. 2007;16(3):195–203.
15. Isaacs H. Fetal and neonatal hepatic tumors. J Pediatr Surg. 2007;42(11):1797–803.
16. Spector LG, Puumala SE, Carozza SE, Chow EJ, Fox EE, Horel S, et al. Cancer risk among
children with very low birth weights. Pediatrics. 2009;124(1):96–104.
17. Trobaugh-Lotrario AD, López-Terrada D, Li P, Feusner JH. Hepatoblastoma in patients
with molecularly proven familial adenomatous polyposis: Clinical characteristics and
rationale for surveillance screening. Pediatr Blood Cancer. 2018;65(8):1–7.
18. Yang A, Sisson R, Gupta A, Tiao G, Geller JI. Germline APC mutations in hepatoblastoma.
Pediatr Blood Cancer. 2018;65(4).
19. Giardiello FM, Petersen GM, Brensinger JD, Luce MC, Cayouette MC, Bacon J, et al.
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut.
1996;39(6):867–9.
20. Rengifo-Cam W, Jasperson KW, Burt RW, Samadder NJ. Familial adenomatous polyposis.
En: Intestinal Polyposis Syndromes: Diagnosis and Management. Nueva York: Springer
International Publishing; 2016. p. 173-195. https://doi.org/10.1007/978-3-319-28103-
2_11
21. Das CJ, Dhingra S, Gupta AK, Iyer V, Agarwala S. Imaging of paediatric liver tumours with
pathological correlation. Clin Radiol. 2009 Oct;64(10):1015–25.
22. Turcotte L, Georgieff M, Ross J, Feusner J, Tomlinson G, Malogolowkin M, et al. Neonatal
Medical Exposures and Characteristics of Low Birth Weight Hepatoblastoma Cases: A
Report From the Children’s Oncology Group. Pediatr Blood Cancer. 2014;23(1):1–7.
23. Feusner J, Plaschkes J. Hepatoblastoma and low birth weight: A trend or chance
observation? Med Pediatr Oncol. 2002;39(5):508–9.
24. Hiyama E. Pediatric hepatoblastoma: diagnosis and treatment. Transl Pediatr.
2014;3(4):293–9.
25. Tanimura M, Matsui I, Abe J, Ikeda H, Kobayashi N, Ohira M, et al. Increased risk of
hepatoblastoma among immature children with a lower birth weight. Cancer Res.
1998;58(14):3032–5.
26. Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human
fetus. Scand J Clin Lab Invest. 1956;8(2):174. Doi: 10.3109/00365515609049266
27. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS. Production of embryonal
alpha-globulin by transplantable mouse hepatomas. Transplantation. 1963 abril;1:174–
80. Doi: 10.1097/00007890-196301020-00004.
28. Abelev G, Assecritova I, Kraevsky N, Perova S, Perevodchikova N. Milestones in liver
disease. J Hepatol. 2002;37:172–5.
29. Trichopoulos D, Sizaret P, Tabor E, Gerety RJ, Martel N, Munoz N, et al. Alphafetoprotein
levels of liver cancer patients and controls in a European population. Cancer.
1980;46(4):736–40.
30. Masopust J, Kithier K, Rádl J, Koutecký J, Kotál L. Occurrence of fetoprotein in patients
with neoplasms and non-neoplastic diseases. Int J Cancer. 1968 mayo 15;3(3):364–73.
31. Linson EA, Hanauer SB. More than a tumor marker⋯A potential role for alpha-feto protein
in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(7):1271–6.
32. Gitlin D, Perricelli A, Gitlin GM. Synthesis of A-Fetoprotein by Liver, Yolk Sac, and
Gastrointestinal Tract of the Human Conceptus. Cancer Res. 1972;32(5):979–82.
33. Maldonado Mercado MG, Pereyra Morales MA, Zenteno Galindo EA. Estructura y función
de la alfa-fetoproteína. Rev Fac Med UNAM. 2015;58(4):5–13. Disponible: https://www.medigraphic.com/pdfs/facmed/un-2015/un154b.pdf [consulta: 2019-10-
30]
34. Taketa K. α-fetoprotein: Reevaluation in hepatology. Hepatology. 1990;12(6):1420–32.
35. Ng K, Mogul DB. Pediatric Liver Tumors. Clin Liver Dis. 2018;22(4):753–72.
36. Men S, Hekimoǧlu B, Tüzün M, Arda IS, Pinar A. Unusual US and CT findings in
hepatoblastoma: A case report. Pediatr Radiol. 1995;25(7):507–8.
37. López-Terrada D, Alaggio R, De Dávila MT, Czauderna P, Hiyama E, Katzenstein H, et al.
Towards an international pediatric liver tumor consensus classification: Proceedings of the
Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27(3):472–91.
38. Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, et al. The
Children’s Hepatic Tumors International Collaboration (CHIC): Novel global rare tumor
database yields new prognostic factors in hepatoblastoma and becomes a research model.
Eur J Cancer. 2016;92–101.
39 Men S, Hekimoglu B, Tuzun M, Arda IS, Pinar A. Unusual US and CT findings in
hepatoblastoma: a case report. Pediatr Radiol. 1995;25(7):507–8.
40. McCarville, M B, Roebuck DJ. Diagnosis and Staging of Hepatoblastoma: Imaging Aspects.
Pediatr Blood Cancer. 2013;60(2, poster 619):S41.
41. Kao SC, McCarville MB. Imaging recommendations for malignant liver neoplasms in
children. Pediatr Blood Cancer. 2006;46(1):2–7.
42. McHugh K, Disini L. Commentary: For the children-s sake, avoid non-contrast CT. Cancer
Imaging. 2011 marzo;11(1):16–8. Doi 10.1102/1470-7330.2011.0003.
43. Shelmerdine SC, Roebuck DJ, Towbin AJ, McHugh K. MRI of paediatric liver tumours: How
we review and report. Cancer Imaging. 2016;16(1):1–10.
44. Sirignano M, Dillman JR, Weiss BD, Quinn CT, Zhang B, Su W, et al. Change in liver, spleen
and bone marrow magnetic resonance imaging signal intensity over time in children with
solid abdominal tumors. Pediatr Radiol. 2018;48(3):325–32.
45. Meeus EM, Zarinabad N, Manias KA, Novak J, Rose HEL, Dehghani H, et al. Diffusionweighted
MRI and intravoxel incoherent motion model for diagnosis of pediatric solid
abdominal tumors. J Magn Reson Imaging. 2018;47(6):1475–86.
46. Shamir SB, Kurian J, Kogan-Liberman D, Taragin BH. Hepatic imaging in neonates and
young infants: State of the art. Radiology. 2017;285(3):763–77.
47. Masand PM. Magnetic resonance imaging features of common focal liver lesions in
children. Pediatr Radiol. 2018;48(9):1234–44.
48. Chung EM, Cube R, Lewis RB, Conran RM. From the archives of the AFIP: Pediatric liver
masses: radiologic-pathologic correlation Part 1. Benign Tumors. Radiographics. 2010
mayo [citado 2019-10-30];30(3):801–26. Disponible en:
https://pubs.rsna.org/doi/10.1148/rg.303095173
49. Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville Goyet J, Gauthier F, et al. 2005
PRETEXT: A revised staging system for primary malignant liver tumours of childhood
developed by the SIOPEL group. Pediatr Radiol. 2007;37(2):123–32.
50. Couinaud C. Liver lobes and segments: notes on the anatomical architecture and surgery
of the liver [artículo en francés]. Presse Med. 1954 mayo 5;62(33):709-12.
51. Cistaro A, Treglia G, Pagano M, Fania P, Bova V, Basso ME, et al. A comparison between FFDG
PET/CT imaging and biological and radiological findings in restaging of
hepatoblastoma patients. Biomed Res Int. 2013;2013.
52. Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in
hepatoblastoma. Lancet Oncol. 2000;1(2):94–100.
53. Aronson DC, Czauderna P, Maibach R, Perilongo G, Morland B. The treatment of
hepatoblastoma: Its evolution and the current status as per the SIOPEL trials. J Indian
Assoc Pediatr Surg. 2014 octubre [citado 2019-10-30];19(4):201–7. Doi: 10.4103/0971-
9261.142001. Disponible en: http://www.jiaps.com/text.asp?2014/19/4/201/142001
54. Towbin AJ, Meyers RL, Woodley H, Miyazaki O, Weldon CB, Morland B, et al. 2017
PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised
for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol. 2018 abril
[citado 2019-10-30];48(4):536–54. Doi: 10.1007/s00247-018-4078-z. Disponible en:
https://link.springer.com/article/10.1007%2Fs00247-018-4078-z
55. Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment
prognostic factors for children with hepatoblastoma - Results from the International
Society of Paediatric Oncology (SIOP) Study SIOPEL 1. Eur J Cancer. 2000;36(11):1418–
25.
56. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful
treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent
chemotherapy and surgery: Final results of the SIOPEL-3HR study. J Clin Oncol.
2010;28(15):2584–90.
57. Baheti AD, Chapman T, Rudzinski E, Albert CM, Stanescu AL. Diagnosis, histopathologic
correlation and management of hepatoblastoma: What the radiologist needs to know. Clin
Imaging. 2018 [citado 2019-10-30];52:273–9. Doi: 10.1016/j.clinimag.2018.08.009.
Disponible en: https://www.clinicalimaging.org/article/S0899-7071(18)30230-4/fulltext
58. Manterola C, Sol M del, Ottone N, Otzen T. Radiological and Surgical Anatomy of the Liver
and Fundamentals of the Various Options Liver Resections. Int J Morphol.
2017;35(4):1525–40.
59. Meyers RL, Tiao G, De Ville de Goyet J, Superina R, Aronson DC. Hepatoblastoma state of
the art. Curr Opin Pediatr. 2014;26(1):29-36.
60. Yadav SS, Lawande MA, Patkar DA, Pungavkar SP. Rare case of hemorrhagic brain
metastasis from hepatoblastoma. J Pediatr Neurosci 2012;7:73-4. | |
